Bertino, E. M., Bekaii-Saab, T., Fernandez, S., Diasio, R. B., Karim, N. A., Otterson, G. A., & Villalona-Calero, M. A. (2012). A Phase II Study of Modulated-Capecitabine and Docetaxel in Chemonaive Patients with Advanced Non-Small Cell Lung Cancer (NSCLC).
Stile di citazione ChicagoBertino, Erin M., Tanios Bekaii-Saab, Soledad Fernandez, Robert B. Diasio, Nagla A. Karim, Gregory A. Otterson, e Miguel A. Villalona-Calero. A Phase II Study of Modulated-Capecitabine and Docetaxel in Chemonaive Patients With Advanced Non-Small Cell Lung Cancer (NSCLC). 2012.
Citazione MLABertino, Erin M., et al. A Phase II Study of Modulated-Capecitabine and Docetaxel in Chemonaive Patients With Advanced Non-Small Cell Lung Cancer (NSCLC). 2012.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.